title: Alpha-methyldopa-induced autoimmune hemolytic anemia in the third trimester of pregnancy.
abstract: Alpha-methyldopa has been demonstrated to be safe for use during pregnancy and is now used to treat gestational hypertension. In pregnancy, alpha-methyldopa-induced autoimmune hemolytic anemia does not have typical features and the severity of symptoms ranges from mild fatigue to dyspnea, respiratory failure, and death if left untreated. A case of alpha-methyldopa-induced autoimmune hemolytic anemia in a 36-year-old gravida 2, para 1 woman at 37(+6) weeks of gestation is reported herein along with the differential diagnostic procedure and the potential risks to the mother and the fetus.
authors.affiliation: 2nd Department of Obstetrics and Gynecology, Medical School of Athens, Aretaieion University Hospital, Vas. Sofias Avenue, 11528 Athens, Greece.
authors.forename: Charalampos
authors.initials: C
authors.lastname: Grigoriadis
authors.forename: Aliki
authors.initials: A
authors.lastname: Tympa
authors.forename: Angelos
authors.initials: A
authors.lastname: Liapis
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Hassiakos
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Bakas